Inventor · disambiguated record
Roland Kontermann
Also filed as: KONTERMANN ROLAND · KONTERMANN ROLAND E
25 granted patents·7 pending applications·199 citations·filing 1999–2024
95Inventor score
Files withUNIV STUTTGART17ONCOMATRYX BIOPHARMA S L3BIONTECH RNA PHARMACEUTICALS GMBH2KONTERMANN ROLAND2PFIZENMAIER KLAUS2
Top patents by PatentIndex Score
32 records- 0195US12065472B2Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivityUNIV STUTTGART·Filed 2021·Granted Aug 20, 2024·3 cites·21 claims
- 0293US12173046B2TNFR2 agonists with improved stabilityUNIV STUTTGART·Filed 2024·Granted Dec 24, 2024·1 cites·7 claims
- 0393US10428120B2Serum half-life extension using IgBDUNIV STUTTGART·Filed 2017·Granted Oct 1, 2019·19 cites·6 claims
- 0491US6759518B1Single-chain multiple antigen-binding molecule, its preparation and useVECTRON THERAPEUTICS AG·Filed 1999·Granted Jul 6, 2004·108 cites·19 claims
- 0590US11142558B2Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivityUNIV STUTTGART·Filed 2018·Granted Oct 12, 2021·5 cites·19 claims
- 0687US7838637B2Single-chain multiple antigen-binding molecule, its preparation and useAFFITECH RES AS·Filed 2004·Granted Nov 23, 2010·22 cites·20 claims
- 0786US8859739B2Anti-huTNFR1 antibody and methods of use thereof for treatmentKONTERMANN ROLAND·Filed 2011·Granted Oct 14, 2014·19 cites·16 claims
- 0885US10875928B2IgM and IgE heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificityUNIV STUTTGART·Filed 2017·Granted Dec 29, 2020·4 cites·18 claims
- 0982US11780926B2Multivalent binding moleculesUNIV STUTTGART·Filed 2018·Granted Oct 10, 2023·3 cites·8 claims
- 1079US11008402B2Antigen binding protein against HER3UNIV STUTTGART·Filed 2017·Granted May 18, 2021·3 cites·14 claims
- 1179US10301368B2Cytokine fusion proteinsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted May 28, 2019·4 cites·22 claims
- 1277US10137202B2Antibody-drug conjugates and immunotoxinsONCOMATRYX BIOPHARMA S L·Filed 2015·Granted Nov 27, 2018·4 cites·33 claims
- 1373US10570206B2Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereofUNIV STUTTGART·Filed 2017·Granted Feb 25, 2020·1 cites·18 claims
- 1469US10428149B2Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereofUNIV STUTTGART·Filed 2016·Granted Oct 1, 2019·1 cites·23 claims
- 1569US9045535B2huTNFR1 selective antagonistsUNIV STUTTGART·Filed 2013·Granted Jun 2, 2015·2 cites·4 claims
- 1666US12378323B2IgM and IgE heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificityUNIV STUTTGART·Filed 2020·Granted Aug 5, 2025·0 cites·25 claims
- 1761US2009326206A1Single-chain Multiple Antigen-binding Molecule, Its Preparation and UseKONTERMANN ROLAND·Filed 2009·Application pending·0 cites
- 1859US2022267410A1TNFR2 Agonists with Improved StabilityUNIV STUTTGART·Filed 2020·Application pending·0 cites
- 1955US8404238B2huTNFR1 selective antagonistsPFIZENMAIER KLAUS·Filed 2008·Granted Mar 26, 2013·0 cites·9 claims
- 2053US10864278B2Antibody-drug conjugates and immunotoxinsONCOMATRYX BIOPHARMA S L·Filed 2018·Granted Dec 15, 2020·0 cites·17 claims
- 2152US10808019B2Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligandsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Oct 20, 2020·0 cites·21 claims
- 2251US9822179B2Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereforPFIZENMAIER KLAUS·Filed 2012·Granted Nov 21, 2017·0 cites·17 claims
- 2350US2022396635A1Trivalent binding moleculesUNIV STUTTGART·Filed 2020·Application pending·0 cites
- 2450US2022372147A1Binding modules comprising modified ehd2 domainsUNIV STUTTGART·Filed 2020·Application pending·0 cites
- 2548US2015056159A1The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual SpecificityUNIVERSIT T STUTTGART·Filed 2013·Application pending·0 cites
- 2647US2004053329A1Endoglin-specific polypeptide, production and use thereofFiled 2001·Application pending·0 cites
- 2747US2014220017A1Serum half-life extension using igbdUNIV STUTTGART·Filed 2012·Application pending·0 cites
- 2846US11851489B2Heterodimerizing Ig domainsUNIV STUTTGART·Filed 2018·Granted Dec 26, 2023·0 cites·6 claims
- 2946US6841385B2Transcription factor E2F DNA-binding domain inhibitor peptides and their useTOPOTARGET UK LTD·Filed 2001·Granted Jan 11, 2005·0 cites·16 claims
- 3041US10689452B2Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereofUNIV STUTTGART·Filed 2017·Granted Jun 23, 2020·0 cites·24 claims
- 3139US9422365B2Peptide or arrangement of peptides forming a Staphylococcus aureus epitope binding siteJULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG·Filed 2012·Granted Aug 23, 2016·0 cites·20 claims
- 3228US10004812B2Antibody-drug conjugates and immunotoxinsONCOMATRYX BIOPHARMA S L·Filed 2015·Granted Jun 26, 2018·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Roland Kontermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →